Cargando…
Evaluation of serum neutrophil gelatinase‐associated lipocalin in older patients with chronic kidney disease
OBJECTIVE: Chronic kidney disease (CKD) is a major health‐care burden all over the world, and aging is an important risk factor for end‐stage renal disease (ESRD). Neutrophil gelatinase‐associated lipocalin (NGAL) has been confirmed as a novel marker for early diagnosis of acute kidney injury. Other...
Autores principales: | Guo, Lulu, Zhu, Bei, Yuan, Haichuan, Zhao, Weihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099757/ https://www.ncbi.nlm.nih.gov/pubmed/32232190 http://dx.doi.org/10.1002/agm2.12098 |
Ejemplares similares
-
Evaluation value of neutrophil gelatinase‐associated lipocalin for the renal dysfunction of patients with chronic kidney disease: A meta‐analysis
por: Guo, Lulu, et al.
Publicado: (2018) -
Neutrophil Gelatinase‐Associated Lipocalin in Cats with Naturally Occurring Chronic Kidney Disease
por: Wang, I.‐C., et al.
Publicado: (2016) -
Plasma neutrophil gelatinase-associated lipocalin and kidney graft outcome
por: Kremer, Daan, et al.
Publicado: (2021) -
Serum neutrophil gelatinase-associated lipocalin and recovery of kidney graft function after transplantation
por: Hollmen, Maria E, et al.
Publicado: (2014) -
Monomeric neutrophil gelatinase associated lipocalin is associated with tubulointerstitial damage in chronic kidney disease
por: Nickolas, Thomas L., et al.
Publicado: (2012)